Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aryastha Life Sciences provides integrated drug discovery and development services as a CRO/CDMO. The team has extensive experience supporting over 75 integrated projects, filing more than 11 INDs, and developing six clinical candidates across oncology, autoimmune diseases, metabolic disorders, and infectious diseases. The company leverages advanced technologies in medicinal chemistry, biology, DMPK studies, analytical support (HPLC/NMR), and scalable manufacturing infrastructure to accelerate client programs from conception through preclinical candidate nomination.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aryastha Life Sciences.